Muscle Spasticity Treatment Market
According to Intent Market Research, the Muscle Spasticity Treatment Market is expected to grow from USD 2.5 billion in 2024-e at a CAGR of 7.6% to touch USD 3.9 billion by 2030. The Muscle Spasticity Treatment Market is dominated by key players such as, Allergan (Acquired by AbbVie), AbbVie Inc., Mylan N.V., Pfizer Inc., and UCB Pharma.